Research graph
References from Impact of glucagon-like peptide-1 receptor agonist or glucagon-like peptide-1 receptor agonist/glucose-dependent insulinotropic polypeptide receptor agonists after bariatric surgery in the veteran population. Local targets link to admitted publications; unresolved targets remain external evidence.
Expert panel report: guidelines (2013) for the management of overweight and obesity in adults
2014 · External reference
Medical care use and expenditures associated with adult obesity in the United States
10.1001/jama.2017.21063 · 2018 · External reference
The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012
10.1001/jamasurg.2013.3654 · 2014 · External reference
Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes
10.1001/jama.2018.14433 · 2018 · External reference
Weight regain after bariatric surgery: scope of the problem, causes, prevention, and treatment
10.1007/s11892-023-01498-z · 2023 · External reference
Once-weekly semaglutide in adults with overweight or obesity
10.1056/nejmoa2032183 · 2021 · External reference
Tirzepatide once weekly for the treatment of obesity
10.1056/nejmoa2206038 · 2022 · External reference
A Randomized, Controlled Trial of 3.0 mg of liraglutide in Weight Management
10.1056/nejmoa1411892 · 2015 · External reference
Estimate of metabolic and bariatric procedures performed in the United States
10.1016/j.soard.2022.06.284 · 2022 · External reference
10.1016/j.soard.2012.12.010
10.1016/j.soard.2012.12.010 · 2013 · External reference
Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery
10.1016/j.soard.2016.02.013 · 2016 · External reference
Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery
10.1111/cob.12323 · 2019 · External reference
